Results 241 to 250 of about 35,140 (296)

Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study. [PDF]

J Cancer Surviv
Maas A, Maurice-Stam H, van der Aa-van Delden AM, van Dalen EC, van Dulmen-den Broeder E, Tissing WJE, Loonen JJ, van der Pal HJH, de Vries ACH, van den Heuvel-Eibrink MM, Janssens GO, Ronckers C, Neggers S, Bresters D, Louwerens M, Versluys BAB, van der Heiden-van der Loo M, Kremer LCM, van Gorp M, Grootenhuis MA, Dutch LATER study group.   +20 more
europepmc   +1 more source

Inhibition of Autophagy Reveals ATR Protein Kinase as a Key Mediator of Cisplatin Sensitivity in Osteosarcoma

Cancer Medicine, Volume 15, Issue 3, March 2026.
ATRi blocks phosphorylation of p53 (S15) and enhances cell death in cisplatin‐treated osteosarcoma cells. ABSTRACT Introduction Osteosarcoma (OS) is the most common primary malignant bone tumor. Although the introduction of chemotherapy has improved the survival rate of OS patients, chemoresistance remains a major clinical problem underlying poor ...
Janice S. Pereira, Gabriel Rosa, Aine Pears, Beata Burczynska, Britta Stordal, Scott J. Roberts, Helen C. Roberts   +6 more
wiley   +1 more source

Dacomitinib as a First‐Line Therapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Real‐world evidence regarding the use of dacomitinib as a first‐line therapy for advanced non‐small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations remains limited. This multicenter, retrospective cohort study aimed to evaluate the clinical outcomes of dacomitinib as a first‐line treatment in patients
Ping‐Chih Hsu, How‐Wen Ko, Li‐Chung Chiu, Shih‐Hao Huang, Chung‐Shu Lee, Yu‐Ching Lin, Scott Chih‐Hsi Kuo, Jia‐Shiuan Ju, Chin‐Chou Wang, Cheng‐Ta Yang   +9 more
wiley   +1 more source

Use of Follow-Up Psycho-Oncology Consultations in Urological Cancer after Transition from Inpatient to Outpatient Care.

Oncol Res Treat
Fugmann D, Holsteg S, Schäfer R, Kreuznacht L, Speer D, Niegisch G, Dinger U, Karger A.   +7 more
europepmc   +1 more source

Evaluation of Anticancer Therapy‐Related Tumor Flare Reaction: Insights From Food and Drug Administration's Adverse Event Reporting System Dataset

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Aim Tumor flare reaction (TFR) is characterized by an increase in tumor size during immunotherapy, often resembling disease progression. This study explores the relationship between anti‐tumor drugs and tumor flare reaction (TFR) through the FAERS database to assist clinicians in better patient management.
Wei Wang, Jiayuan Cui, Yuxuan Bo, Yuxuan Wang, Zhipeng Sun, Xin Guan, Baoan Hong, Ning Zhang   +7 more
wiley   +1 more source

Integration of HIV Status in Cancer Surveillance in South Africa: A Call for Action

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Human immunodeficiency virus (HIV) increases the risk of developing cancer. We aimed to assign HIV status to cancers diagnosed in public laboratories recorded in the National Cancer Registry (NCR) in South Africa, guided by HIV counselling and testing guidelines.
Carole Metekoua, Tracey Wiggill, Tinashe Tombe‐Nyahuma, Yann Ruffieux, Judith Mwansa‐Kambafwile, Stanford Kwenda, Tafadzwa G. Dhokotera, Julia Bohlius, Eliane Rohner, Mazvita Muchengeti   +9 more
wiley   +1 more source

The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy for Mismatch Repair Proficient (pMMR)/Microsatellite Stable (MSS) Colorectal Cancer Liver Metastases (CRLM)

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Purpose To assess the effectiveness and safety of hepatic arterial infusion chemotherapy (HAIC) in patients with mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer liver metastases (CRLM) who are resistant to standard treatments.
Yawei Li, Junqing Xi, Xiaoyu Huang, Yingen Luo, Xiaowu Zhang, Xiao Li   +5 more
wiley   +1 more source

Financial Toxicity in Patients With Breast Cancer Treated at Private Medicine Institutions in Brazil

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Financial toxicity (FT) refers to the negative impact of the financial burden of cancer diagnosis and treatment on patients' well‐being. With rising global costs of oncologic therapies, diagnostics, and supportive care, FT has become a key concern in cancer care, influencing adherence, quality of life, and outcomes.
Aline Cristini Vieira, Matheus Costa e Silva, Cristiano De Padua Souza, Luciana Castro Garcia Landeiro, Max Senna Mano   +4 more
wiley   +1 more source

Smoking, Alcohol, and Their Interaction in the Risk of Head and Neck Cancer: A Nationwide Cohort Study

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Smoking and alcohol drinking are established causes of head and neck cancer (HNC), yet their combined effect and variation by anatomic sub‐site remain incompletely defined. Methods We followed 5,985,244 Korean adults (≥ 30 years) who attended National Health Insurance health screening in 2002–2003 until 31 December 2019.
Eunjung Park, Hee‐Yeon Kang, Yuh‐Seog Jung, Byungmi Kim, Thi Tra Bui, Jin‐Kyoung Oh   +5 more
wiley   +1 more source

Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Pediatric malignancies have emerged as the leading cause of disease‐related mortality in children, exhibiting distinct etiological and molecular characteristics compared to adult cancers. Despite advances in genomic profiling, the molecular landscape of pediatric solid tumors, particularly in Chinese populations, remains ...
Bingxiao Yan, Jinhu Wang, Jieni Xiong, Shuangai Liu, Yinbing Tang, Ziqi He, Hujin Yan, Bize Guo, Chen Chen, Yijie Zhang, Qinfang Zhu, Jiabin Cai, Min He, Xuan Wu, Junqing Mao, Lifeng Zhang, Weizhong Gu, Zhu Zhu, Zheming Li, Rui Xiao, Qiang Shu, Gang Yu, Ting Tao   +22 more
wiley   +1 more source